Table 7.
Rectum group | Colon group | p-value | |
---|---|---|---|
Cases, n | 41 | 176 | – |
Males, n | 24 | 93 | 0.510 |
Age (years) | 44.88 ± 14.26 | 43.90 ± 14.55 | 0.697 |
Vital status | 8 | 42 | 0.551 |
Days to death (days) | 599.88 ± 468.76 | 853.74 ± 806.69 | 0.395 |
NA | 8 | 134 | – |
Days to last follow-up (days) | 876.48 ± 691.48 | 995.50 ± 952.63 | 0.501 |
NA | 8 | 42 | – |
Pathologic stage | |||
Stage I | 4 | 22 | 0.698 |
Stage II | 15 | 74 | |
Stage III | 15 | 48 | |
StageVI | 6 | 24 | |
NA | 1 | 8 | – |
Pathology T stage | |||
T1 | 2 | 4 | 0.757 |
T2 | 4 | 23 | |
T3 | 30 | 125 | |
T4 | 5 | 24 | |
Pathology N stage | |||
N0 | 19 | 104 | 0.062 |
N1 | 12 | 50 | |
N2 | 9 | 22 | |
NX | 1 | 0 | |
Pathology M stage | |||
M0 | 31 | 120 | 0.279 |
M1 | 6 | 24 | |
MX | 3 | 31 | |
NA | 1 | 1 | – |
A total of 217 clinical samples with RNA-seq data from Broad Institute’s GDAC Firehose were included. The tables compiled the clinical characteristics of CRC in different sites from Broad Institute’s GDAC Firehose